Discordant phenotype and sterol biochemistry in Smith-Lemli-Opitz syndrome.

Abstract

Smith-Lemli-Opitz syndrome (SLOS) is a malformation syndrome resulting from mutations of the 7-dehydrocholesterol reductase (DHCR7) gene. During cholesterol biosynthesis, DHCR7 catalyzes the conversion of 7-dehydrocholesterol (7DHC) to cholesterol. A clinical diagnosis of SLOS is confirmed biochemically by the presence of elevated levels of 7DHC. Phenotypic severity of SLOS has previously been shown to correlate with the 7DHC/cholesterol ratio. We describe a patient with a severe SLOS phenotype, but a very low serum 7DHC/cholesterol ratio. We show that this discordance is due to alternative splicing of a previously unreported IVS5+3 A>T mutation. This mutation results in the transcription of both normal and mutant mRNA transcripts. We postulate that alternative splicing of the IVS5+3 A>T results in insufficient DHCR7 activity during embryogenesis, but sufficient DHCR7 activity once cholesterol synthetic rates decrease postnatally. This unique case underscores the adjunctive use of fibroblast and molecular testing in ambiguous cases of SLOS and may provide insight into the potential efficacy of therapeutic interventions altering postnatal cholesterol biosynthesis.

• Authors: Grace Koo, Sandra K Conley, Christopher A Wassif, Forbes D Porter
• Journal: American journal of medical genetics. Part A (Am J Med Genet A) Vol. 152A Issue 8 Pg. 2094-8 (Aug 2010) ISSN: 1552-4833 [Electronic] United States
• PMID: 20635399 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Intramural)

Chemical References

• Dehydrocholesterols
• Cholesterol
• 7-dehydrocholesterol
• Oxidoreductases Acting on CH-CH Group Donors
• 7-dehydrocholesterol reductase

Topics

• Adult
• Cholesterol (metabolism)
• Dehydrocholesterols (metabolism)
• Female
• Humans
• Infant, Newborn
• Male
• Mutation (genetics)
• Oxidoreductases Acting on CH-CH Group Donors (genetics)
• Phenotype
• Smith-Lemli-Opitz Syndrome (diagnosis, genetics, metabolism)